Natural Investments LLC Buys Shares of 2,481 Intuitive Surgical, Inc. $ISRG

Key Points

• Natural Investments LLC has purchased 2,481 shares of Intuitive Surgical, Inc., valued at approximately $1,348,000 during the second quarter.
• Multiple analysts have updated their ratings on Intuitive Surgical, with Wall Street Zen upgrading the stock from "hold" to "buy," while the average rating remains "Moderate Buy" with a price target of $589.43.
• Insiders have sold a total of 45,224 shares of Intuitive Surgical stock, valued at $21,716,492 in the last three months, indicating significant insider selling activity.

Natural Investments LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 2,481 shares of the medical equipment provider's stock, valued at approximately $1,348,000.

A number of other large investors have also recently modified their holdings of the business. Richardson Financial Services Inc. boosted its holdings in shares of Intuitive Surgical by 339.8% in the 2nd quarter. Richardson Financial Services Inc. now owns 1,526 shares of the medical equipment provider's stock valued at $821,000 after purchasing an additional 1,179 shares in the last quarter. Trust Co. of Toledo NA OH acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $167,000. Williams & Novak LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $498,000. PDS Planning Inc boosted its holdings in shares of Intuitive Surgical by 42.5% in the 2nd quarter. PDS Planning Inc now owns 2,264 shares of the medical equipment provider's stock valued at $1,230,000 after purchasing an additional 675 shares in the last quarter. Finally, JB Capital LLC boosted its holdings in shares of Intuitive Surgical by 11.4% in the 2nd quarter. JB Capital LLC now owns 459 shares of the medical equipment provider's stock valued at $249,000 after purchasing an additional 47 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, October 4th. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $589.43.

Intuitive Surgical Stock Down 3.2%

Shares of NASDAQ:ISRG opened at $429.59 on Friday. The firm has a market cap of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.66 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The business has a fifty day simple moving average of $458.68 and a 200 day simple moving average of $497.98.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the company earned $1.78 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last three months. Insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.